• Latest Posts
Interview 18 Dec 2019

How BioNTech Navigates the Biotech Fundraising Maze

European Biotech: The Insider View

Update: BioNTech Files for €141M Nasdaq IPO

BioNTech Raises Whopping €290M to Fund Personalized mRNA Vaccines for Cancer

Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials

What Does the Largest Biotech IPO Ever Mean for European Biotech?


Pfizer Offers €374M for German mRNA Flu Vaccine

In Depth 15 Oct 2019

Four New Technologies That Will Change Cancer Treatment

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Scancell and BioNTech Will Combine Their Expertise to Fight Cancer

German Biotech Raises Record $270M Series A for Individualized Cancer Therapies

US Biotech Unicorn Steps up Competition for BioNTech’s mRNA Personalized Cancer Vaccine